23-year-old Sarah was born with systemic idiopathic juvenile arthritis, causing her to develop dysautonomia and a variety of severe autoimmune-related disorders with no known cure. Sarah’s doctors predicted she would die prematurely in her early 20’s. After seeing her friend with juvenile arthritis, Tucker Beau, begin to show significant improvements from Celltex stem cell therapy, Sarah decided to give it a try.